Conformational Landscape of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Non-Nucleoside Inhibitor Binding Pocket: Lessons for Inhibitor Design from a Cluster Analysis of Many Crystal Structures

被引:32
|
作者
Paris, Kristina A. [1 ,2 ]
Haq, Omar [1 ,2 ]
Felts, Anthony K. [1 ,2 ]
Das, Kalyan [1 ,3 ]
Arnold, Eddy [1 ,3 ]
Levy, Ronald M. [1 ,2 ]
机构
[1] Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Biomaps Inst Quantitat Biol, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
关键词
EXCHANGE MOLECULAR-DYNAMICS; HIGH-RESOLUTION STRUCTURES; DRUG-RESISTANT STRAINS; DOUBLE-STRANDED DNA; ANGSTROM RESOLUTION; HIV-1; RT; POSITIONAL ADAPTABILITY; WILD-TYPE; PROTEIN; COMPLEXES;
D O I
10.1021/jm900854h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Clustering of 99 available X-ray crystal structures of HIV-1 reverse transcriptase (RT) at the flexible non-nucleoside inhibitor binding pocket (NNIBP) provides information about features of the conformational landscape for binding non-nucleoside inhibitors (NNRTIs), including effects of mutation and crystal forms. The ensemble of NNIBP conformations is separated into eight discrete clusters based primarily on the position of the functionally important primer grip, the displacement of which is believed to be one of the mechanisms of inhibition of RT. Two of these clusters are populated by structures in which the primer grip exhibits novel conformations that differ from the predominant cluster by over 4 A and are induced by the unique inhibitors capravirine and rilpivirine/TMC278. This work identifies a new conformation of the NNIBP that may be used to design NNRTIs. It can also be used to guide more complete exploration of the NNIBP free energy landscape using advanced sampling techniques.
引用
收藏
页码:6413 / 6420
页数:8
相关论文
共 27 条
  • [1] Identification of a Non-Nucleoside Reverse Transcriptase Inhibitor against Human Immunodeficiency Virus-1
    Kim, Min-Jung
    Yu, Kyung Lee
    Han, Ri
    Lee, Yoonji
    Oh, Kyungsoo
    You, Ji Chang
    ACS INFECTIOUS DISEASES, 2023, 9 (08): : 1582 - 1592
  • [2] The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations
    Wang, J.
    Liang, H.
    Bacheler, L.
    Wu, H.
    Deriziotis, K.
    Demeter, L. M.
    Dykes, C.
    VIROLOGY, 2010, 402 (02) : 228 - 237
  • [3] Integrative approaches in HIV-1 non-nucleoside reverse transcriptase inhibitor design
    Poongavanam, Vasanthanathan
    Namasivayam, Vigneshwaran
    Vanangamudi, Murugesan
    Al Shamaileh, Hadi
    Veedu, Rakesh N.
    Kihlberg, Jan
    Murugan, N. Arul
    WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2018, 8 (01)
  • [4] Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors
    Battini, Leandro
    Bollini, Mariela
    MEDICINAL RESEARCH REVIEWS, 2019, 39 (04) : 1235 - 1273
  • [5] Recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 non-nucleoside reverse transcriptase inhibitor binding pocket
    Gu, Shuang-Xi
    Xiao, Ting
    Zhu, Yuan-Yuan
    Liu, Gen-Yan
    Chen, Fen-Er
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 174 : 277 - 291
  • [6] Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance
    Gupta, Soumi
    Fransen, Signe
    Paxinos, Ellen E.
    Stawiski, Eric
    Huang, Wei
    Petropoulos, Christos J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 1973 - 1980
  • [7] Dipyridodiazepinone Analogs as Human Immunodeficiency Virus Type 1-Specific Non-Nucleoside Reverse Transcriptase Inhibitors: An Overview
    Lv, M.
    Xu, H.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (18) : 1874 - 1898
  • [8] Crystal Structure of HIV-1 Reverse Transcriptase Bound to a Non-Nucleoside Inhibitor with a Novel Mechanism of Action
    Freisz, Severine
    Bec, Guillaume
    Radi, Marco
    Wolff, Philippe
    Crespan, Emmanuele
    Angeli, Lucilla
    Dumas, Philippe
    Maga, Giovanni
    Botta, Maurizio
    Ennifar, Eric
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (10) : 1805 - 1808
  • [9] Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms
    Li, Dongyue
    Zhan, Peng
    De Clercq, Erik
    Liu, Xinyong
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (08) : 3595 - 3613
  • [10] Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure
    Gatanaga, H
    Hachiya, A
    Kimura, S
    Oka, S
    VIROLOGY, 2006, 344 (02) : 354 - 362